The “smart” drug Modafinil, which many students take to improve their ability to study and increase exam success does not increase cognition and slows reaction time, according to a study in PLOS ONE. Read more and read the study.

‘Smart’ drug not beneficial

Bariatric surgeries compared

New guidelines for treating cancer of the esophagus

November 2014 e-Edition

Using mobile technology to engage nursing staff

Caring for patients in respiratory failure

Creating high-performance interprofessional teams

Connecting leadership at the bedside to improvement

Do you hear what I hear? Combating alarm fatigue

Staying healthy: Advice for telehealth nurses

Synchronicity: Meeting Mother Teresa

Evolution or revolution? Smartphone use in nursing practice

Issues up close

Brushing up on mouth care for cancer patients with mucositis

Leadership insights

What’s new in anticoagulation for patients with atrial fibrillation?

Travel nursing, anyone?

Best practices for integrating technology into nurse communication processes

Nursing practice and work environment

Stroke in a child with sickle cell anemia

What you need to know about electronic documentation

From your ANA President and ANF Chair

Improved patient handoffs reduces medical errors

Drugs for diabetic neuropathy similarly effective despite cost differences

FDA approves vaccine for meningococcal disease

Ebola resources

Placebos are ‘more effective than no treatment’ for children’s coughs

FDA approves new labeling for Embeda ER capsules

Staggering number of alarms identified

Study finds link between vitamin D and prostate cancer

Ebola information from ANA

Non-polio enterovirus resources from the CDC

Vaccine and immunization information center from CDC

CDC Ebola information digital hub

FDA approves two drugs for idiopathic pulmonary fibrosis

CDC develops new faster test for enterovirus D68